Skip to main content
TipRanks
Go Ultimate75% OFF

Basilea Pharmaceutica (BSLN) Q4 2025 Earnings Report

9 Followers

CH:BSLN Q4 2025 EPS Results

Actual EPS
CHF 1.99
Consensus EPS
CHF 1.64
Beat/Miss
Beat by +CHF 0.35
One Year Ago EPS
CHF 4.70

CH:BSLN Q4 2025 Revenue Results

Actual Revenue
CHF 128.42M
Expected Revenue
CHF 120.50M
Beat/Miss
Beat by +CHF 7.92M
YoY Revenue Growth
-2.90%

Earnings Announcement Details

Quarter
Q4 2025
Date
02/17/2026
Time
Before Open
Conference Call
Tuesday, February 17, 2026
CH:BSLN Upcoming Earnings

Basilea Pharmaceutica's next earnings date is estimated for February 16, 2027, based on past reporting schedules.

Q4 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2025 Earnings Slide Deck

Q4 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:BSLN Earnings History

CH:BSLN earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 16, 20272026 (Q4)5.92-1.99――
Aug 18, 20262026 (Q2)3.342.131.2669.05% (+0.87)
Feb 17, 20262025 (Q4)1.641.994.7-57.70% (-2.71)
Aug 19, 20252025 (Q2)2.031.261.57-20.00% (-0.32)
Feb 18, 20252024 (Q4)3.244.70-1.71375.66% (+6.41)
Aug 13, 20242024 (Q2)1.171.572.43-35.21% (-0.86)
Feb 13, 20242023 (Q4)-2.02-1.712.05-183.17% (-3.75)
Aug 15, 20232023 (Q2)0.812.43-1.03336.02% (+3.46)
Feb 14, 20232022 (Q4)-1.302.051.2662.70% (+0.79)
Aug 16, 20222022 (Q2)-1.29-1.03-1.8444.02% (+0.81)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed